ornithine has been researched along with Hepatic Encephalopathy in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (47.37) | 18.7374 |
1990's | 3 (5.26) | 18.2507 |
2000's | 3 (5.26) | 29.6817 |
2010's | 12 (21.05) | 24.3611 |
2020's | 12 (21.05) | 2.80 |
Authors | Studies |
---|---|
Vilchez, RA; Wang, X | 1 |
Dalal, A; Jain, A; Kumar, A; Mahajan, B; Sachdeva, S; Sharma, BC; Sonika, U; Srivastava, S | 1 |
Faccioli, J; Gioia, S; Nardelli, S; Ridola, L; Riggio, O | 1 |
Galle, PR; Labenz, C; Labenz, J | 1 |
Bajaj, JS; Bukofzer, S; Devarakonda, KR; Jamil, K; Potthoff, A; Pyrsopoulos, N; Rahimi, RS; Ram Bhamidimarri, K; Safadi, R; Thabut, D; Wang, L | 1 |
Da, BL; Kovalic, AJ; Lee, TP | 1 |
Alimirah, M; Gordon, SC; Sadiq, O | 1 |
Bajaj, JS; Bhamidimarri, KR; Bukofzer, S; Potthoff, A; Pyrsopoulos, N; Rahimi, RS; Safadi, R; Thabut, D | 1 |
Tapper, EB | 2 |
Bémeur, C; Bosoi, CR; Clément, MA; Oliveira, MM; Rose, CF; Tremblay, M | 1 |
Brown, KA; Brown, RS; Flamm, SL; Rahimi, RS | 1 |
Arias, N; Hadjihambi, A; Jalan, R; Sheikh, M | 1 |
Amodio, P; Ampuero, J | 1 |
Rathi, S; Taneja, S | 1 |
Goyal, O; Kaur, N; Kishore, H; Sharma, BC; Sidhu, SS | 1 |
Alsahhar, JS; Rahimi, RS | 1 |
Jalan, R; Jover-Cobos, M; Noiret, L; Sharifi, Y | 1 |
Rahimi, RS; Rockey, DC | 1 |
Sussman, NL | 1 |
Cross, TJ; Ellul, MA; Gholkar, SA | 1 |
Kristiansen, RG; Rose, CF; Ytrebø, LM | 1 |
Kristiansen, RG | 1 |
Arranz, JA; Córdoba, J; Oria, M; Raguer, N; Riudor, E; Romero-Giménez, J | 1 |
DAVIDSON, CS; FAST, BB; STORMONT, JM; WOLFE, SJ | 1 |
Hutchinson, JH; Labby, DH | 1 |
BROWN, H | 1 |
Davies, NA; Hodges, SJ; Jalan, R; Wright, G | 1 |
Blanke, CD; Chan, JS; Harding, CO | 1 |
Grossi, CE; Prytz, B; Rousselot, LM | 2 |
Dupuy, R; Thiroloix, J | 1 |
Ferenci, P; Wewalka, F | 1 |
Herlong, HF; Maddrey, WC; Walser, M | 1 |
Batshaw, ML; Brusilow, SW; Walser, M | 1 |
Albrecht, J; Hilgier, W; Januszewski, S; Kapuściński, A; Quack, G | 1 |
Grauffel, C; Knödgen, B; Sarhan, S; Seiler, N | 1 |
Albrecht, J; Hilgier, W; Januszewski, S; Quack, G | 1 |
Holovach, IIu; Mytnyk, ZM; Neĭko, IeM | 1 |
Brant, PC; Hamlyn, AN; Hildrew, P; James, IM | 1 |
Chainuvati, T; Plengvanit, U; Viranuvatti, V | 1 |
Imler, M | 1 |
Hartung, HD | 1 |
Albrecht, J; Hilgier, W | 1 |
Zieve, L | 1 |
Chandler, MD; McCandless, DW; Sears, ES | 1 |
Boswell, M; Hoogenraad, NJ; Thaler, MM | 1 |
Ziegler, K | 1 |
Leonhardt, H | 1 |
Hegedüs-Wein, I; Szám, I; Szentner, J; Szilárd, T; Vass, A | 1 |
Müting, D | 1 |
Bungert, HJ; Leonhardt, H | 1 |
Costa, AA; Ganc, AJ; Miszputen, SJ; Reibscheid, S; Vilela, MP | 1 |
Melzer, H; Weber, D; Wotzka, R | 1 |
Merveille, P; Molimard, R; Paris, J | 1 |
Coudert, AJ; Lajoinie, J; Planche, R | 1 |
Nordmann, R | 1 |
12 review(s) available for ornithine and Hepatic Encephalopathy
Article | Year |
---|---|
Novel Therapies in Hepatic Encephalopathy.
Topics: Acetylcarnitine; Albumins; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Hepatic Encephalopathy; Humans; Nootropic Agents; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Surface-Active Agents | 2020 |
Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes.
Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Length of Stay; Mortality; Ornithine; Rifaximin; Secondary Prevention | 2021 |
Hepatic encephalopathy: a critical current review.
Topics: Albumins; Ammonia; Anti-Bacterial Agents; Bile Acids and Salts; Brain; Brain Edema; Cognitive Dysfunction; Dipeptides; Energy Metabolism; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Portasystemic Shunt, Surgical; Prognosis; Psychometrics; Severity of Illness Index; Synaptic Transmission | 2018 |
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc | 2019 |
Ornithine phenylacetate revisited.
Topics: Animals; Brain; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Liver Diseases; Liver Failure; Ornithine; Rats | 2013 |
Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.
Topics: Ammonia; Carbon; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Ornithine; Oxides; Phenylbutyrates; Polyethylene Glycols; Urea | 2015 |
Treatment of Overt Hepatic Encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin | 2015 |
Hepatic encephalopathy due to liver cirrhosis.
Topics: Albumins; Amino Acids; Diagnosis, Differential; Diet; Disaccharides; Drug Resistance; Electroencephalography; Glycerol; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Neomycin; Neurologic Examination; Nucleic Acid Synthesis Inhibitors; Ornithine; Phenylbutyrates; Probiotics; Protein Synthesis Inhibitors; Rifamycins; Rifaximin; Terminal Care; Tomography, X-Ray Computed | 2015 |
Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.
Topics: Animals; Drug Delivery Systems; Glycine; Hepatic Encephalopathy; Humans; Hyperammonemia; Ornithine; Treatment Outcome | 2016 |
Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
Topics: Ammonia; Animals; Glutamate-Ammonia Ligase; Health Knowledge, Attitudes, Practice; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Failure; Ornithine; Treatment Outcome | 2016 |
Conditional deficiencies of ornithine or arginine.
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Animals; Arginine; Citrulline; Female; Glycine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Lysine; Models, Biological; Ornithine; Orotic Acid; Pregnancy; Protein Deficiency; Urease | 1986 |
[Pathogenesis and treatment of portal encephalopathy].
Topics: Alkalosis; Alkalosis, Respiratory; Anti-Bacterial Agents; Arginine; Asparagine; Brain; Collateral Circulation; Diet Therapy; Dietary Proteins; Enema; Fructose; Galactose; Hepatic Encephalopathy; Humans; Hypertension, Portal; Ischemia; Liver Diseases; Memory Disorders; Mental Disorders; Neomycin; Nervous System Diseases; Neurologic Manifestations; Ornithine; Portacaval Shunt, Surgical | 1971 |
7 trial(s) available for ornithine and Hepatic Encephalopathy
Article | Year |
---|---|
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Topics: Ammonia; Aspartic Acid; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Rifaximin; Tumor Necrosis Factor-alpha | 2022 |
Pharmacokinetics/pharmacodynamics of L-ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes.
Topics: Adult; Ammonia; Hepatic Encephalopathy; Humans; Ornithine; Phenylacetates | 2022 |
Letter to the editor: l-ornithine l-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Topics: Ammonia; Aspartic Acid; Dipeptides; Double-Blind Method; Hepatic Encephalopathy; Humans; Ornithine | 2022 |
Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial.
Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Treatment Outcome | 2021 |
The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy.
Topics: Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Ammonia; Calcium; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Keto Acids; Ketoglutaric Acids; Male; Middle Aged; Nitrogen; Ornithine | 1980 |
[Amino acids prevent hepatic encephalopathy. Ornithine-aspartate in hyperammonemia--results of a study].
Topics: Ammonia; Aspartic Acid; Clinical Trials as Topic; Double-Blind Method; Hepatic Encephalopathy; Humans; Ornithine | 1989 |
[On the therapy of liver diseases with ornithine aspartate].
Topics: Acute Disease; Alanine Transaminase; Ammonia; Aspartic Acid; Bilirubin; Cholangitis; Chronic Disease; Drug Tolerance; Fatty Liver; Hepatic Encephalopathy; Hepatitis; Humans; Iron; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Ornithine; Sulfobromophthalein | 1969 |
38 other study(ies) available for ornithine and Hepatic Encephalopathy
Article | Year |
---|---|
Population Pharmacokinetic Analysis to Assist Dose Selection of the L-Ornithine Salt of Phenylacetic Acid.
Topics: Adult; Ammonia; Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Ornithine; Phenylacetates | 2022 |
Letter to the editor: Episodic-precipitant-induced hepatic encephalopathy treatment: Look at new and old precipitants!
Topics: Aspartic Acid; Double-Blind Method; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Ornithine | 2022 |
Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis?
Topics: Aspartic Acid; Dipeptides; Double-Blind Method; Hepatic Encephalopathy; Humans; Ornithine; Prognosis | 2022 |
A Trial of Ornithine Phenylacetate and the Arc of Ammonia's History in the Management of Overt Hepatic Encephalopathy.
Topics: Ammonia; Hepatic Encephalopathy; Humans; Ornithine | 2021 |
Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammonia.
Topics: Ammonia; Animals; Antigens, Nuclear; Anxiety; Apoptosis; Behavior, Animal; Bile Ducts; Caspase 3; Cerebrovascular Circulation; Disease Models, Animal; Hepatic Encephalopathy; Hyperammonemia; Hypotension; Ligation; Male; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Ornithine; Rats; Rats, Sprague-Dawley | 2021 |
Reply.
Topics: Ammonia; Hepatic Encephalopathy; Humans; Ornithine | 2021 |
Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat.
Topics: Aspartic Acid; Dipeptides; Hepatic Encephalopathy; Humans; Ornithine | 2018 |
Terminating and episode of overt hepatic encephalopathy: L-ornithine-L-aspartate may have some role.
Topics: Aspartic Acid; Dipeptides; Hepatic Encephalopathy; Humans; Ornithine | 2018 |
Reply.
Topics: Aspartic Acid; Hepatic Encephalopathy; Humans; Ornithine | 2018 |
Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
Topics: Amino Acids; Ammonia; Animals; Brain; Disease Models, Animal; Evoked Potentials, Motor; Glutamine; Hepatic Encephalopathy; Male; Ornithine; Phenylacetates; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley | 2012 |
Treatment of hepatic coma: use of certain Krebs' urea cycle intermediates (L-arginine, DL-ornithine).
Topics: Amino Acids; Ammonia; Arginine; Citric Acid Cycle; Hepatic Encephalopathy; Humans; Ornithine; Urea | 1958 |
STUDIES OF RAT LIVER AND KIDNEY ENZYMES. II. RESPONSE TO DIETARY PROTEIN DEFICIENCY AND REPLETION DURING CHRONIC ADMINISTRATION OF AMMONIUM ACETATE AND L-GLUTAMINE.
Topics: Acetates; Adaptation, Physiological; Ammonia; Arginine; Dietary Proteins; Enzymes; Glutamates; Glutamine; Hepatic Encephalopathy; Kidney; Kwashiorkor; Liver; Ornithine; Protein Deficiency; Rats; Research | 1964 |
MECHANISM OF HEPATIC COMA IN SURGERY.
Topics: Ammonia; Blood; Hepatic Encephalopathy; Humans; Ligases; Liver; Liver Function Tests; Neurologic Manifestations; Ornithine; Ornithine Carbamoyltransferase; Portacaval Shunt, Surgical; Postoperative Complications | 1964 |
L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
Topics: Ammonia; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver; Models, Biological; Muscle, Skeletal; Ornithine; Phenylacetates | 2007 |
Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Topics: Adult; Arginine; Carcinoma, Hepatocellular; Citrulline; Female; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Neoplasms; Ornithine; Ornithine Carbamoyltransferase Deficiency Disease; Orotic Acid; Polymorphism, Single-Stranded Conformational; Syndrome | 2008 |
Amino acids mixtures in prevention of acute ammonia intoxication in dogs.
Topics: Ammonia; Animals; Aspartic Acid; Blood Urea Nitrogen; Dogs; Hepatic Encephalopathy; Ornithine; Portal Vein | 1967 |
[Critical study of venous blood ammonia in hepatic coma. Diagnosis, surveillance and treatment].
Topics: Adult; Aged; Ammonia; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Ornithine | 1967 |
[Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
Topics: Amino Acids; Ammonia; Arginine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Ornithine; Parenteral Nutrition | 1980 |
Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Ammonia; Argininosuccinate Synthase; Argininosuccinic Acid; Argininosuccinic Aciduria; Carbamoyl-Phosphate Synthase (Ammonia); Carbamyl Phosphate; Child; Child, Preschool; Coma; Female; Hepatic Encephalopathy; Humans; Infant; Infant, Newborn; Ketoglutaric Acids; Ligases; Lyases; Male; Middle Aged; Ornithine; Ornithine Carbamoyltransferase Deficiency Disease | 1980 |
Increase of the brain uptake index for L-ornithine in rats with hepatic encephalopathy.
Topics: Acetates; Animals; Aspartic Acid; Blood-Brain Barrier; Brain; Endothelium; Hepatic Encephalopathy; Male; Models, Biological; Ornithine; Rats; Rats, Wistar; Thioacetamide | 1994 |
Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.
Topics: Amino Acids; Animals; Behavior, Animal; Brain; Citrulline; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Liver; Male; Mice; Motor Activity; Ornithine; Ornithine-Oxo-Acid Transaminase; Thioacetamide; Urea | 1993 |
Contrasting effects of thioacetamide-induced liver damage on the brain uptake indices of ornithine, arginine and lysine: modulation by treatment with ornithine aspartate.
Topics: Animals; Arginine; Blood-Brain Barrier; Brain; Chemical and Drug Induced Liver Injury; Dipeptides; Hepatic Encephalopathy; Infusions, Intravenous; Lysine; Male; Ornithine; Rats; Rats, Wistar; Thioacetamide | 1996 |
[Different therapeutic approaches for chronic diffuse liver lesions using ornicetil, lactulose, etimizol and corinfar].
Topics: Etimizol; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Middle Aged; Nifedipine; Ornithine; Treatment Outcome | 2002 |
Effect of ornithine alpha oxoglutarate on brain metabolism in patients with chronic liver disease.
Topics: Adult; Aged; Amino Acids, Dicarboxylic; Blood Glucose; Brain; Carbon Dioxide; Cerebral Cortex; Chronic Disease; Electroencephalography; Female; Glucose; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Ketoglutaric Acids; Lactates; Liver Diseases; Male; Middle Aged; Ornithine; Oxygen; Oxygen Consumption; Regional Blood Flow | 1975 |
Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
Topics: Acute Disease; Adult; Ammonia; Chronic Disease; Drug Evaluation; Female; Hepatic Encephalopathy; Humans; Ketoglutaric Acids; Male; Middle Aged; Ornithine | 1977 |
[Present-day therapy of hepatic encephalopathy (author's transl)].
Topics: Acid-Base Imbalance; Ammonia; Anemia; Anti-Bacterial Agents; Exchange Transfusion, Whole Blood; Glucose; Hepatic Encephalopathy; Humans; Hypoxia; Intestinal Mucosa; Ketoglutaric Acids; Kidney; Lactulose; Liver Cirrhosis; Ornithine; Perfusion; Prognosis; Renal Dialysis | 1976 |
Arginine in thioacetamide-induced hepatogenic encephalopathy in rats: activation of enzymes of arginine metabolism to glutamate.
Topics: Animals; Arginase; Arginine; Brain; Enzyme Activation; Female; Glutamates; Glutamic Acid; Hepatic Encephalopathy; Ornithine; Ornithine-Oxo-Acid Transaminase; Rats; Rats, Inbred Strains; Thioacetamide | 1986 |
Disruption of the blood-brain barrier in hyperammonemic coma and the pharmacologic effects of dexamethasone and difluoromethyl ornithine.
Topics: Acetates; Ammonia; Animals; Blood-Brain Barrier; Coma; Dexamethasone; Eflornithine; Exploratory Behavior; Female; Grooming; Hepatic Encephalopathy; Mice; Mice, Inbred Strains; Ornithine | 1985 |
Reye's syndrome due to a novel protein-tolerant variant of ornithine-transcarbamylase deficiency.
Topics: Ammonia; Brain Diseases; Child; Fatty Liver; Female; Hepatic Encephalopathy; Humans; Kinetics; Liver; Metabolism, Inborn Errors; Ornithine; Ornithine Carbamoyltransferase; Prothrombin Time; Reye Syndrome; Urea | 1974 |
[Current views on the therapy of hepatic coma].
Topics: Acute Kidney Injury; Adolescent; Amino Acids; Ammonia; Anti-Bacterial Agents; Arginine; Aspartic Acid; Coenzyme A; Diet Therapy; Exchange Transfusion, Whole Blood; Glutamates; Hepatic Encephalopathy; Humans; Malates; Male; NAD; Ornithine; Prednisone; Prognosis; Renal Dialysis; Thiamine Pyrophosphate; Thioctic Acid; Vasopressins | 1970 |
[Pathogenesis and therapy of exogenous hepatic coma].
Topics: Amino Acids; Aspartic Acid; Brain; Dipeptides; Electroencephalography; Hepatic Encephalopathy; Humans; Hypertension, Portal; Liver Cirrhosis; Ornithine; Water-Electrolyte Balance | 1973 |
[Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
Topics: Amino Acids, Dicarboxylic; Ammonia; Animals; Drug Evaluation; Female; Hepatic Encephalopathy; Humans; Injections, Intravenous; Ketoglutaric Acids; Male; Middle Aged; Ornithine; Poisoning; Rats | 1974 |
[Therapy of severe hyperammonemia].
Topics: Adult; Aged; Ammonia; Anti-Bacterial Agents; Aspartic Acid; Diet Therapy; Enzyme Induction; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Ornithine | 1972 |
[Effects of the arginine-ornithine combination on the arterial ammonia levels in chronic liver diseases and hepatic coma].
Topics: Ammonia; Arginine; Chronic Disease; Hepatic Encephalopathy; Humans; Methods; Ornithine; Uremia | 1968 |
[1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
Topics: Brain Diseases; Electroencephalography; Hepatic Encephalopathy; Hepatitis; Humans; Ketoglutaric Acids; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Ornithine | 1970 |
[Apropos of the alpha-ketoglutarate of (+) orinithine in the treatment of beginning forms or confirmed delirium].
Topics: Glutarates; Hepatic Encephalopathy; Humans; Male; Middle Aged; Ornithine; Psychoses, Alcoholic | 1967 |
Metabolic buffers in hepatic failure.
Topics: Adenosine Triphosphate; Amino Acids; Ammonia; Animals; Blood Glucose; Blood Urea Nitrogen; Diet Therapy; Dogs; Glucose; Hepatic Encephalopathy; Keto Acids; Lactates; Liver Cirrhosis; Liver Diseases; Ornithine; Ornithine Carbamoyltransferase; Portacaval Shunt, Surgical | 1968 |
[Therapy of hyperammoniemia].
Topics: Adenosine Triphosphate; Ammonia; Anti-Bacterial Agents; Arginine; Aspartic Acid; Citrulline; Dietary Proteins; Hepatic Encephalopathy; Humans; Intestines; Malates; Ornithine | 1969 |